Professor of Biomedical Sciences Michael Blaber recently developed a treatment for Fuchs’ dystrophy, a degenerative and incurable disease of the eye and specifically, the cornea. Blaber, who co-founded Trefoil Therapeutics to support the further creation of treatments for corneal disease, answered five questions about his research and its future. Read more ...
|